VAERS reports by lot

Moderna COVID-19 lot 053B22A: VAERS reports

86 VAERS reports list lot 053B22A as a Moderna COVID-19 vaccine, received between 2022-08-14 and 2023-07-26. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
86
Reports
6%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular3823%
General / Systemic (non-local)2817%
Neurological2716%
Respiratory1610%
Injection-site / Local reaction127%
Gastrointestinal106%
Musculoskeletal95%
Thrombotic / Hematological85%
Dermatological (non-injection-site)74%
Allergic / Anaphylactic53%
Psychiatric / Neuropsychiatric42%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois7
New Mexico6
California5
Texas5
Ohio5
Louisiana4
Washington4
Georgia4
New York3
Nevada3
Hawaii3
Colorado3

Reports by month received

2022-0815
2022-0928
2022-1011
2022-1110
2022-1212
2023-013
2023-023
2023-031
2023-062
2023-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.